NR2E1 and aniridia: Studying a proband group made up primarily of aniridia (72.5% [58/80]) and ASD (23.75% [19/80]) and enriched for cases with no evidence of PAX6 mutation (82.5% [66/80]), we identified 17 NR2E1 variants (Table 3).